Literature DB >> 24902643

A rare case of multifocal intramedullary germinoma in cervical spinal cord.

R Wang1, X Fan2, B Zhang3.   

Abstract

STUDY
DESIGN: Case report.
OBJECTIVES: We present for the first time a patient with multifocal intramedullary cervical spinal cord germ cell tumors with elevated serum alpha-fetoprotein (AFP).
SETTING: Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
METHODS: A 19-year-old girl experienced numbness in her right leg 10 months before diagnosis. The numbness gradually became severe and extended up to the thorax. Magnetic resonance imaging (MRI) visualized several intramedullary masses with intensive enhancement and extensive peritumoral edema in the spinal cord at the C3-T1 vertebral body levels. Administration of methylprednisolone caused no treatment effect. The largest mass, which was located at the T1 level inside the normal spinal cord and confirmed by naked eye observation, was completely extracted under a microscope. Postoperative pathological examination demonstrated the so-called 'two-cell pattern,' which is typical of germinoma with placental alkaline phosphatase expression. The serum level of AFP was 64.50 ng ml(-1) (normal range: 0-5 ng ml(-1)). The residual tumor was eliminated through radiation therapy (local 30 Gy) following surgery. Afterward, the patient's neurological deficits were improved but not resolved.
RESULTS: Six years after surgery, no recurrence was encountered and the patient remained stable.
CONCLUSION: Radiotherapy is the salvage therapy for spinal cord germinoma. Steroids were of no therapeutic value in the treatment of intramedullary spinal cord germinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24902643     DOI: 10.1038/sc.2014.33

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  1 in total

Review 1.  Primary extramedullary spinal germinoma: case report and review of the literature.

Authors:  Qiang Hu; Wenhua Yu; Quan Du; Qiang Zhu; Zhihao Che
Journal:  Neurosurg Rev       Date:  2016-11-07       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.